US Patent 10004746 | Patents | Expiry | Expiration | Dates

PHARMACYCLICS INC

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

United States Flag United States

Post An Enquiry

Virtual Booth

IBRUTINIB

Supporting Information : Click here to upload a PDF

US Patent Number

10004746

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2031-06-03

Patent Use Code

U-2241

Delist Requested

Application Number

205552

Patent Use Description

Product Number

2

PHARMACYCLICS INC

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

United States Flag United States

Post An Enquiry

Virtual Booth

IBRUTINIB

Supporting Information : Click here to upload a PDF

US Patent Number

10004746

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2031-06-03

Patent Use Code

U-1684

Delist Requested

Application Number

205552

Patent Use Description

TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA

Product Number

2

PHARMACYCLICS INC

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

United States Flag United States

Post An Enquiry

Virtual Booth

IBRUTINIB

Supporting Information : Click here to upload a PDF

US Patent Number

10004746

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2031-06-03

Patent Use Code

U-1684

Delist Requested

Application Number

205552

Patent Use Description

TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA

Product Number

1

PHARMACYCLICS INC

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

United States Flag United States

Post An Enquiry

Virtual Booth

IBRUTINIB

Supporting Information : Click here to upload a PDF

US Patent Number

10004746

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2031-06-03

Patent Use Code

U-1946

Delist Requested

Application Number

205552

Patent Use Description

Product Number

1

PHARMACYCLICS INC

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

United States Flag United States

Post An Enquiry

Virtual Booth

IBRUTINIB

Supporting Information : Click here to upload a PDF

US Patent Number

10004746

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2031-06-03

Patent Use Code

U-1946

Delist Requested

Application Number

205552

Patent Use Description

Product Number

2

PHARMACYCLICS INC

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

United States Flag United States

Post An Enquiry

Virtual Booth

IBRUTINIB

Supporting Information : Click here to upload a PDF

US Patent Number

10004746

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2031-06-03

Patent Use Code

U-2242

Delist Requested

Application Number

205552

Patent Use Description

Product Number

2

PHARMACYCLICS INC

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

United States Flag United States

Post An Enquiry

Virtual Booth

IBRUTINIB

Supporting Information : Click here to upload a PDF

US Patent Number

10004746

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2031-06-03

Patent Use Code

U-2241

Delist Requested

Application Number

205552

Patent Use Description

Product Number

1

PHARMACYCLICS INC

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

United States Flag United States

Post An Enquiry

Virtual Booth

IBRUTINIB

Supporting Information : Click here to upload a PDF

US Patent Number

10004746

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2031-06-03

Patent Use Code

U-2242

Delist Requested

Application Number

205552

Patent Use Description

Product Number

1

PHARMACYCLICS INC

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

United States Flag United States

Post An Enquiry

Virtual Booth

IBRUTINIB

Supporting Information : Click here to upload a PDF

US Patent Number

10004746

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2031-06-03

Patent Use Code

U-1946

Delist Requested

Application Number

210563

Patent Use Description

Product Number

3

PHARMACYCLICS INC

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

United States Flag United States

Post An Enquiry

Virtual Booth

IBRUTINIB

Supporting Information : Click here to upload a PDF

US Patent Number

10004746

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2031-06-03

Patent Use Code

U-2241

Delist Requested

Application Number

210563

Patent Use Description

Product Number

3

PHARMACYCLICS INC

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

United States Flag United States

Post An Enquiry

Virtual Booth

IBRUTINIB

Supporting Information : Click here to upload a PDF

US Patent Number

10004746

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2031-06-03

Patent Use Code

U-2242

Delist Requested

Application Number

210563

Patent Use Description

Product Number

3

PHARMACYCLICS INC

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

United States Flag United States

Post An Enquiry

Virtual Booth

IBRUTINIB

Supporting Information : Click here to upload a PDF

US Patent Number

10004746

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2031-06-03

Patent Use Code

U-2241

Delist Requested

Application Number

210563

Patent Use Description

Product Number

1

PHARMACYCLICS INC

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

United States Flag United States

Post An Enquiry

Virtual Booth

IBRUTINIB

Supporting Information : Click here to upload a PDF

US Patent Number

10004746

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2031-06-03

Patent Use Code

U-2242

Delist Requested

Application Number

210563

Patent Use Description

Product Number

4

PHARMACYCLICS INC

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

United States Flag United States

Post An Enquiry

Virtual Booth

IBRUTINIB

Supporting Information : Click here to upload a PDF

US Patent Number

10004746

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2031-06-03

Patent Use Code

U-1684

Delist Requested

Application Number

210563

Patent Use Description

TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA

Product Number

4

PHARMACYCLICS INC

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

United States Flag United States

Post An Enquiry

Virtual Booth

IBRUTINIB

Supporting Information : Click here to upload a PDF

US Patent Number

10004746

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2031-06-03

Patent Use Code

U-1684

Delist Requested

Application Number

210563

Patent Use Description

TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA

Product Number

3

PHARMACYCLICS INC

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

United States Flag United States

Post An Enquiry

Virtual Booth

IBRUTINIB

Supporting Information : Click here to upload a PDF

US Patent Number

10004746

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2031-06-03

Patent Use Code

U-2242

Delist Requested

Application Number

210563

Patent Use Description

Product Number

2

PHARMACYCLICS INC

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

United States Flag United States

Post An Enquiry

Virtual Booth

IBRUTINIB

Supporting Information : Click here to upload a PDF

US Patent Number

10004746

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2031-06-03

Patent Use Code

U-1946

Delist Requested

Application Number

210563

Patent Use Description

Product Number

2

PHARMACYCLICS INC

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

United States Flag United States

Post An Enquiry

Virtual Booth

IBRUTINIB

Supporting Information : Click here to upload a PDF

US Patent Number

10004746

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2031-06-03

Patent Use Code

U-1684

Delist Requested

Application Number

210563

Patent Use Description

TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA

Product Number

1

PHARMACYCLICS INC

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

United States Flag United States

Post An Enquiry

Virtual Booth

IBRUTINIB

Supporting Information : Click here to upload a PDF

US Patent Number

10004746

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2031-06-03

Patent Use Code

U-2242

Delist Requested

Application Number

210563

Patent Use Description

Product Number

1

PHARMACYCLICS INC

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

United States Flag United States

Post An Enquiry

Virtual Booth

IBRUTINIB

Supporting Information : Click here to upload a PDF

US Patent Number

10004746

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2031-06-03

Patent Use Code

U-2241

Delist Requested

Application Number

210563

Patent Use Description

Product Number

4

PHARMACYCLICS INC

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

United States Flag United States

Post An Enquiry

Virtual Booth

IBRUTINIB

Supporting Information : Click here to upload a PDF

US Patent Number

10004746

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2031-06-03

Patent Use Code

U-1946

Delist Requested

Application Number

210563

Patent Use Description

Product Number

4

PHARMACYCLICS INC

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

United States Flag United States

Post An Enquiry

Virtual Booth

IBRUTINIB

Supporting Information : Click here to upload a PDF

US Patent Number

10004746

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2031-06-03

Patent Use Code

U-2241

Delist Requested

Application Number

210563

Patent Use Description

Product Number

2

PHARMACYCLICS INC

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

United States Flag United States

Post An Enquiry

Virtual Booth

IBRUTINIB

Supporting Information : Click here to upload a PDF

US Patent Number

10004746

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2031-06-03

Patent Use Code

U-1684

Delist Requested

Application Number

210563

Patent Use Description

TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA

Product Number

2

PHARMACYCLICS INC

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

United States Flag United States

Post An Enquiry

Virtual Booth

IBRUTINIB

Supporting Information : Click here to upload a PDF

US Patent Number

10004746

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2031-06-03

Patent Use Code

U-1946

Delist Requested

Application Number

210563

Patent Use Description

Product Number

Find

Information, Expiry & Status of FDA Orange Book Patents covering 10004746

2031-06-03

U-2241

2

2031-06-03

U-1684

TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA

2

2031-06-03

U-1684

TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA

1

2031-06-03

U-1946

1

2031-06-03

U-1946

2

2031-06-03

U-2242

2

2031-06-03

U-2241

1

2031-06-03

U-2242

1

2031-06-03

U-1946

3

2031-06-03

U-2241

3

2031-06-03

U-2242

3

2031-06-03

U-2241

1

2031-06-03

U-2242

4